AngioDynamics (ANGO) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- BofA lifts targets on AMD and ARM, raises CPU TAM to $170bn
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
July 16, 2015 4:01 PM EDTFourth quarter fiscal 2015 net sales of $90.9 million; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash generation of $10.8 million; Full year operating cash generation of $26.2 million Preliminary FY2016 guidance of 2% - 4% sales growth and 7% - 14% adjusted EPS growth
ALBANY, N.Y., July 16, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider... More
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
July 16, 2015 4:01 PM EDTFourth quarter fiscal 2015 net sales of $90.9 million; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash generation of $10.8 million; Full year operating cash generation of $26.2 million Preliminary FY2016 guidance of 2% - 4% sales growth and 7% - 14% adjusted EPS growth
ALBANY, N.Y., July 16, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider... More
